Information  X 
Enter a valid email address

Company Name matching 'NuCana plc'

Date
Time Source
Company
Announcement
28 Apr 2021 1:00 pm GNW   NuCana plc NuCana to Participate in the 7th Annual Truist Securities Life Sciences Summit
10 Apr 2021 1:30 pm GNW   NuCana plc NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021
04 Mar 2021 9:01 pm GNW   NuCana plc NuCana Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Update
25 Feb 2021 1:00 pm GNW   NuCana plc NuCana to Participate in Three Upcoming Investor Conferences
15 Jan 2021 1:01 pm GNW   NuCana plc NuCana Presents Encouraging Data at ASCO GI for NUC-3373 in Heavily Pre-Treated Patients with Metastatic Colorectal Cancer
21 Dec 2020 9:01 pm GNW   NuCana plc NuCana Appoints Andrew Kay as Board Chairman
30 Nov 2020 9:01 pm GNW   NuCana plc Final Data from the Phase Ib Study of Acelarin plus Cisplatin in Patients with Advanced Biliary Tract Cancer Published Online Ahead of Print in The Oncologist
19 Nov 2020 9:01 pm GNW   NuCana plc NuCana Reports Third Quarter 2020 Financial Results and Provides Business Update
17 Nov 2020 9:01 pm GNW   NuCana plc NuCana to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
12 Nov 2020 9:01 pm GNW   NuCana plc NuCana to Present at the Jefferies Virtual London Healthcare Conference
13 Oct 2020 9:01 pm GNW   NuCana plc NuCana Expands its Board of Directors with the Appointment of Bali Muralidhar
21 Sep 2020 9:02 pm GNW   NuCana plc NuCana Presents Three Posters at the ESMO Virtual Congress 2020
  9:01 pm GNW   NuCana plc NuCana Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
17 Sep 2020 12:00 pm GNW   NuCana plc NuCana Announces Pricing of a Public Offering of American Depositary Shares
16 Sep 2020 9:01 pm GNW   NuCana plc NuCana Announces Proposed Public Offering of American Depositary Shares
19 Aug 2020 9:01 pm GNW   NuCana plc NuCana Reports Second Quarter 2020 Financial Results and Provides Business Update
27 May 2020 12:00 pm GNW   NuCana plc NuCana to Present at the 2020 Jefferies Virtual Healthcare Conference
19 May 2020 9:01 pm GNW   NuCana plc NuCana Reports First Quarter 2020 Financial Results and Provides Business Update
18 May 2020 12:00 pm GNW   NuCana plc NuCana Announces the Re-Opening of Enrollment in Multiple Clinical Studies After Temporary Pause Due to COVID-19 Pandemic
15 May 2020 12:00 pm GNW   NuCana plc NuCana to Present Two Abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2020
05 May 2020 9:01 pm GNW   NuCana plc NuCana Announces Re-Opening of Global Phase III Study of Acelarin Plus Cisplatin in Patients with Biliary Tract Cancer (NuTide:121)
02 Apr 2020 9:01 pm GNW   NuCana plc NuCana Provides Update on Impact of COVID-19 on Clinical Studies
10 Mar 2020 8:02 pm GNW   NuCana plc NuCana Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update
  8:01 pm GNW   NuCana plc NuCana Reports Preliminary Data from Phase II Study of Single-Agent Acelarin (NUC-1031) in Patients with Platinum-Resistant Ovarian Cancer
04 Mar 2020 12:00 pm GNW   NuCana plc NuCana Receives Positive Opinion for Orphan Drug Designation in the European Union for Acelarin (NUC-1031) for the Treatment of Patients with Biliary Tract Cancer
25 Feb 2020 12:00 pm GNW   NuCana plc NuCana to Present at the Cowen and Company 40th Annual Health Care Conference
27 Jan 2020 12:00 pm GNW   NuCana plc NuCana Announces First Patients Dosed in Both US and Europe in Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer
26 Nov 2019 12:00 pm GNW   NuCana plc NuCana to Participate in the Piper Jaffray 31st Annual Healthcare Conference
14 Nov 2019 12:00 pm GNW   NuCana plc NuCana to Present at the Jefferies 2019 London Healthcare Conference
13 Nov 2019 9:01 pm GNW   NuCana plc NuCana Reports Third Quarter 2019 Financial Results and Provides Business Update
29 Oct 2019 11:00 am GNW   NuCana plc NuCana Presents Data at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
25 Oct 2019 12:00 pm GNW   NuCana plc NuCana Announces FDA Clearance to Commence Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer
29 Aug 2019 1:00 pm GNW   NuCana plc NuCana to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
27 Aug 2019 1:00 pm GNW   NuCana plc NuCana to Participate in Citi’s 14th Annual Biotech Conference
21 Aug 2019 9:01 pm GNW   NuCana plc NuCana Reports Second Quarter 2019 Financial Results and Provides Business Update
20 Aug 2019 1:00 pm GNW   NuCana plc Enrollment in the Independent Investigator-Sponsored Phase III Metastatic Pancreatic Study ACELARATE Has Been Suspended Following a Prespecified Futility Analysis
17 Jul 2019 12:00 pm GNW   NuCana plc NuCana Announces First Patients Dosed in Phase I Study of NUC-7738
13 Jun 2019 12:24 am GNW   NuCana plc NuCana Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Acelarin® for the Treatment of Biliary Tract Cancer
30 May 2019 9:01 pm GNW   NuCana plc NuCana to Present at the Jefferies 2019 Healthcare Conference
14 May 2019 9:01 pm GNW   NuCana plc NuCana Reports First Quarter 2019 Financial Results and Provides Business Update
02 Apr 2019 1:00 pm GNW   NuCana plc NuCana to Participate in the William Blair 3rd Late-Stage Therapeutics Conference
07 Mar 2019 9:01 pm GNW   NuCana plc NuCana Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Business Update
05 Mar 2019 1:00 pm GNW   NuCana plc NuCana to Present at the Cowen and Company 39th Annual Health Care Conference
27 Feb 2019 9:45 pm GNW   NuCana plc NuCana to Present at the American Association for Cancer Research (AACR) Annual Meeting 2019
25 Jan 2019 1:15 pm GNW   NuCana plc NuCana plc Announces Withdrawal of Public Offering of ADSs
23 Jan 2019 9:01 pm GNW   NuCana plc NuCana plc Announces Proposed Public Offering of ADSs
28 Nov 2018 9:01 pm GNW   NuCana plc NuCana to Participate in Citi's 2018 Global Healthcare Conference
27 Nov 2018 9:01 pm GNW   NuCana plc NuCana Reports Third Quarter 2018 Financial Results and Provides Business Update
20 Nov 2018 12:00 pm GNW   NuCana plc NuCana to Participate in the 2018 Evercore ISI HealthCONx Conference
07 Nov 2018 12:00 pm GNW   NuCana plc NuCana to Participate in the Jefferies 2018 London Healthcare Conference
01 Nov 2018 11:00 am GNW   NuCana plc NuCana Announces First Patients Enrolled in Phase Ib Study of NUC-3373 in Advanced Colorectal Cancer
22 Oct 2018 12:00 pm GNW   NuCana plc NuCana Presents Data from Phase I Study of NUC-3373 at ESMO 2018
21 Oct 2018 11:54 am GNW   NuCana plc NuCana Reports Additional Promising Clinical Data on NUC-1031 (Acelarin®) as Front-Line Treatment of Advanced Biliary Tract Cancer at ESMO 2018
09 Oct 2018 6:15 pm GNW   NuCana plc NuCana to Present New Data from its ProTide Portfolio at the European Society for Medical Oncology (ESMO) 2018 Congress
29 Aug 2018 9:01 pm GNW   NuCana plc NuCana to Participate in Citi’s 13th Annual Biotech Conference
28 Aug 2018 9:01 pm GNW   NuCana plc NuCana Reports Second Quarter 2018 Financial Results and Provides Business Update
23 May 2018 9:01 pm GNW   NuCana plc NuCana Reports First Quarter 2018 Financial Results
21 May 2018 12:00 pm GNW   NuCana plc NuCana Announces Appointment of Cyrille Leperlier to its Board of Directors
09 Apr 2018 12:00 pm GNW   NuCana plc NuCana plc Announces Appointment of Adam George to its Board of Directors
21 Mar 2018 8:08 pm GNW   NuCana plc NuCana Reports Financial Results for the Year Ended December 31, 2017


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t